SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-050282
Filing Date
2022-09-16
Accepted
2022-09-16 16:04:54
Documents
2
Period of Report
2022-09-14

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1558
2 EX-24 DOCUMENT attachment1.htm EX-24 6027
  Complete submission text file 0001209191-22-050282.txt   9085
Mailing Address ACHILLION PHARMACEUTICALS 300 GEORGE STREET NEW HAVEN CT 06511
Business Address
Pottage John C Jr (Reporting) CIK: 0001378587 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40067 | Film No.: 221248104

Mailing Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 250, PMB#052 CARLSBAD CA 92008 415-649-8758
PARDES BIOSCIENCES, INC. (Issuer) CIK: 0001822711 (see all company filings)

IRS No.: 852696306 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations